Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Waters Corporation (NYSE:WAT). In a filing disclosed on October 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in Waters stock on September 30th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Purchased $1,001 - $15,000 in shares of StandardAero NYSE: SARO on 10/1/2025.
- Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 10/1/2025.
- Sold $15,001 - $50,000 in shares of Fortive NYSE: FTV on 9/30/2025.
- Purchased $1,001 - $15,000 in shares of StandardAero NYSE: SARO on 9/30/2025.
- Purchased $1,001 - $15,000 in shares of APi Group NYSE: APG on 9/30/2025.
- Sold $1,001 - $15,000 in shares of GoDaddy NYSE: GDDY on 9/30/2025.
- Purchased $1,001 - $15,000 in shares of PTC NASDAQ: PTC on 9/30/2025.
- Purchased $1,001 - $15,000 in shares of CoStar Group NASDAQ: CSGP on 9/30/2025.
- Purchased $1,001 - $15,000 in shares of Mitsubishi Heavy Industries OTCMKTS: MHVYF on 9/30/2025.
- Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 9/30/2025.
Waters Stock Performance
Shares of WAT opened at $336.83 on Tuesday. The company's fifty day moving average is $300.98 and its 200-day moving average is $323.39. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $423.56. The firm has a market cap of $20.05 billion, a price-to-earnings ratio of 30.37, a price-to-earnings-growth ratio of 3.09 and a beta of 1.04. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55.
Waters (NYSE:WAT - Get Free Report) last announced its quarterly earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 EPS for the quarter. The company had revenue of $608.55 million for the quarter. Waters had a net margin of 21.71% and a return on equity of 38.60%. Equities analysts expect that Waters Corporation will post 12.86 EPS for the current fiscal year.
Institutional Trading of Waters
Hedge funds have recently bought and sold shares of the stock. QRG Capital Management Inc. boosted its holdings in Waters by 85.7% in the 1st quarter. QRG Capital Management Inc. now owns 1,642 shares of the medical instruments supplier's stock valued at $605,000 after purchasing an additional 758 shares during the period. Swedbank AB boosted its holdings in Waters by 25.8% in the 2nd quarter. Swedbank AB now owns 40,526 shares of the medical instruments supplier's stock valued at $14,145,000 after purchasing an additional 8,305 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Waters by 5.6% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 530,697 shares of the medical instruments supplier's stock valued at $195,599,000 after purchasing an additional 28,018 shares during the period. Cambridge Investment Research Advisors Inc. boosted its holdings in Waters by 4.6% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 2,986 shares of the medical instruments supplier's stock valued at $1,101,000 after purchasing an additional 130 shares during the period. Finally, Jacobs Levy Equity Management Inc. acquired a new position in shares of Waters in the 1st quarter valued at $1,244,000. 94.01% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several analysts recently issued reports on WAT shares. Wall Street Zen downgraded shares of Waters from a "buy" rating to a "hold" rating in a report on Saturday, July 26th. Bank of America upped their price objective on shares of Waters from $370.00 to $375.00 and gave the stock a "neutral" rating in a report on Thursday, June 26th. Rothschild & Co Redburn started coverage on shares of Waters in a report on Wednesday, October 8th. They set a "buy" rating and a $390.00 price objective for the company. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Waters in a report on Wednesday, October 8th. Finally, Redburn Partners set a $390.00 price objective on shares of Waters in a report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $377.56.
Read Our Latest Stock Analysis on Waters
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
Waters Company Profile
(
Get Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.